(120 days)
Not Found
No
The device description and performance studies focus on the physical properties and standard testing of latex condoms, with no mention of AI or ML technologies.
No
The device is used for contraceptive and prophylactic (disease prevention) purposes and does not describe any therapeutic function.
No
The device is a condom, used for contraceptive and prophylactic purposes, not for diagnosing any condition or disease.
No
The device is a physical condom made of natural rubber latex, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for contraceptive and prophylactic purposes (preventing pregnancy and STIs). This is a physical barrier method, not a diagnostic test performed in vitro (outside the body) on specimens like blood, urine, or tissue.
- Device Description: The description details a physical device (a condom) made of latex. It does not describe any components or mechanisms for analyzing biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological specimens.
- Detecting specific analytes (e.g., antibodies, antigens, DNA).
- Providing diagnostic information about a patient's health status.
The testing described (bench testing, shelf-life, biocompatibility) is standard for medical devices, but not specifically indicative of an IVD.
N/A
Intended Use / Indications for Use
The Royal Condoms are used for contraceptive and prophylactic purposes (to help prevent pregnancy and the transmission of sexually transmitted infections).
Product codes
HIS
Device Description
The subject condoms are made of a natural rubber latex sheath, which completely covers with a closely fitted membrane. They are single use, non-sterile and available in five versions (natural, black grape, coffee, strawberry and chocolate favored). These condoms are of smooth surface, natural colored in cylindrical shape, straight parallel walled with a reservoir nipple at the closed end and a rim at the open end. These condoms have a minimum length of 182mm, width of 53 - 54mm, and wall thickness between 0.065 - 0.075mm, which comply with ISO 4074.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench Performance: Bench testing demonstrated that the subject condoms met all the requirements of ISO 4074.
Shelf-Life: Results of accelerated shelf-life study support that the subject condoms have a shelf-life of five years from the date of manufacture. The real-time shelf-life study is in progress, as required by 21 CFR § 801.435.
Biocompatibility: The subject condoms have passed the biocompatibility testing in accordance with ODE Guidance Memorandum G95-1 (dated May 1, 1995) and the following standards:
- ISO 10995-5:2009, "Biological Evaluation of Medical Devices - Part 5: Tests for In Vitro Cytotoxicity"
- ISO 10993-10:2010, "Biological Evaluation of Medical Devices - Part 10: Tests for Irritation and Skin Sensitization"
- ISO 10993-11:2006, "Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity"
- ISO 10993-12:2012, "Biological Evaluation of Medical Devices - Part 10: Sample Preparation and Reference Materials"
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.5300 Condom.
(a)
Identification. A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.(b)
Classification. (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized human figure in profile, with three overlapping faces.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 25, 2016
M3 Global Enterprises, LLC % Lara Luzak Senior Regulatory Specialist Registrar Corp. 144 Research Drive Hampton, VA 23666
Re: K161195
Trade/Device Name: Royal Condoms (Natural, Black Grape, Coffee, Strawberry, and Chocolate Flavors) Regulation Number: 21 CFR§ 884.5300 Regulation Name: Condom Regulatory Class: II Product Code: HIS Dated: July 26, 2016 Received: July 27, 2016
Dear Lara Luzak:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Douglas Silverstein -S For Division 2016.08.25 08:06:18 -04'00' Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
510(k) Number (if known) K161195
Device Name
Royal Condoms (Natural, Black Grape, Coffee, Strawberry, and Chocolate Flavors)
Indications for Use (Describe)
The Royal Condoms are used for contraceptive and prophylactic purposes (to help prevent pregnancy and the transmission of sexually transmitted infections).
Type of Use (Select one or both, as applicable)
_ Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (8/14)
3
510(k) Summary (K161195)
I. SUBMITTER
M3 Global Enterprises, LLC 70 Birch Alley Suite 240, Building B Beavercreek, Ohio 45440 USA Contact: Neil Mehta Phone: 1-937-681-9606
II. DATE PREPARED: August 24, 2016
III. DEVICE IDENTIFICATION
| Name of Device: | Royal Condoms (Natural, Black Grape, Coffee, Strawberry, and |
|---|---|
| Chocolate Flavors) | |
| Common or Usual Name: | Condom |
| Regulatory Class: | Class II |
| Regulation: | 21 CFR 884.5300 |
| Product Code: | HIS |
| Classification Panel: | Obstetrics/Gynecology |
IV. PREDICATE DEVICE
Trojan Enz Brand Male Latex Condom (K071313)
V. DEVICE DESCRIPTION
The subject condoms are made of a natural rubber latex sheath, which completely covers with a closely fitted membrane. They are single use, non-sterile and available in five versions (natural, black grape, coffee, strawberry and chocolate favored). These condoms are of smooth surface, natural colored in cylindrical shape, straight parallel walled with a reservoir nipple at the closed end and a rim at the open end. These condoms have a minimum length of 182mm, width of 53 - 54mm, and wall thickness between 0.065 - 0.075mm, which comply with ISO 4074.
VI. GUIDANCE DOCUMENT RELIANCE
The submission adheres to the following FDA guidance documents, which were used to support substantial equivalence:
- Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300
- . Guidance for Industry: Latex Condoms for Men - Information for 510(k) Premarket Notifications: Use of Consensus Standards for Abbreviated Submissions
4
VII. INDICATIONS FOR USE
The Royal Condoms are used for contraceptive and prophylactic purposes (to prevent pregnancy and the transmission of sexually transmitted infections).
VIII. SUBSTANTIAL EQUIVALENCE DISCUSSION
The subject and predicate devices have the same indications. They have the same design and comparable dimensions. Although there are differences in the latex formulations and additives of these devices, the differences do not raise different questions of safety and effectiveness.
IX. PERFORMANCE DATA
Bench Performance: Bench testing demonstrated that the subject condoms met all the requirements of ISO 4074.
Shelf-Life: Results of accelerated shelf-life study support that the subject condoms have a shelf-life of five years from the date of manufacture. The real-time shelf-life study is in progress, as required by 21 CFR § 801.435.
Biocompatibility: The subject condoms have passed the biocompatibility testing in accordance with ODE Guidance Memorandum G95-1 (dated May 1, 1995) and the following standards:
- ISO 10995-5:2009, "Biological Evaluation of Medical Devices - Part 5: Tests for In Vitro Cytotoxicity"
- ISO 10993-10:2010, "Biological Evaluation of Medical Devices - Part 10: Tests for Irritation and Skin Sensitization"
- . ISO 10993-11:2006, "Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity"
- ISO 10993-12:2012, "Biological Evaluation of Medical Devices - Part 10: Sample Preparation and Reference Materials"
X. CONCLUSIONS
Performance data demonstrate that the subject devices are substantially equivalent to the predicate device in terms of safety and effectiveness.